Related Experiment Video
Updated: Mar 10, 2026

09:23
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
14.9K
Biochemical Changes in the Niche Following Tumor Cell Invasion.
A M Decker1, F C Cackowski1,2, Y Jung1
1Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan.
Journal of Cellular Biochemistry
|December 17, 2016
Summary
Metastatic prostate cancer (PCa) targets the bone marrow niche. Understanding the niche
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Metastatic cancer, particularly prostate cancer (PCa), is a major cause of cancer-related mortality.
- PCa preferentially metastasizes to the bone marrow, specifically the endosteal niche.
- The bone marrow niche influences PCa cell fate, including dormancy, reactivation, and therapeutic resistance.
Purpose of the Study:
- To summarize the biochemical signatures of the endosteal niche that influence PCa.
- To review potential therapeutic strategies targeting metastatic PCa within the bone marrow hematopoietic stem cell (HSC) niche.
Main Methods:
- This review synthesizes existing literature on prostate cancer metastasis to the bone marrow.
- It analyzes the role of endosteal niche cells and their secreted molecules.
- The review examines the impact of biochemical factors on PCa cell phenotype and behavior.
Main Results:
- Endosteal cells secrete homing molecules that attract PCa cells to the bone marrow.
- The niche's biochemical signature regulates PCa cell dormancy, reactivation, and resistance to chemotherapy.
- Growth factors, interleukins, adhesion molecules, and extracellular matrix proteins alter PCa cell phenotype.
Conclusions:
- Understanding the biochemical interactions between PCa cells and the bone marrow niche is crucial for developing novel therapies.
- Targeting these niche-specific interactions offers a promising strategy for treating metastatic prostate cancer.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K

